Professional Media briefs: December 2012

Professional Media briefs: December 2012
Professional Media briefs: December 2012

Wiley has announced a deal with the Sheridan Press that gives its online-only journals a retro twist. The agreement makes the digital-only journals available in print through a print-on-demand feature. The deal, which goes into effect in January, will make 145 titles available in printed form.

Nature Publishing Group is giving readers greater insight into what the community is into. The publisher announced that it will be including information such as page views, citation data, media mentions, blog posts and social media shares for articles that are published under the Nature, Nature research journals and Nature Communications imprints. These social metrics will be shown for articles published since 2011.

The American ­Society of Plastic Surgeons kicked off two projects to expand the reach of its research through an information exchange between its publication Plastic and Reconstructive Surgery and the journal of the Brazilian Society of Plastic Surgery, Revista Brasilieria de Cirugia Plastica. ASPS also announced it was creating an international open-access journal called Plastic and Reconstructive Surgery-Global Open. Both start in 2013.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.